Funder: National Institutes of Health

Due Dates: February 24, 2025 (New/Renewal/Resubmission) | February 23, 2026 (New/Renewal/Resubmission)

Funding Amounts: Phase I: up to $350,000 (6 months) | Phase II: up to $2.15M (2 years) | 2 Phase I and 1 Phase II awards anticipated per cycle

Summary: Supports U.S. small businesses developing automated, miniaturized tissue chip systems for drug development and biomedical research, emphasizing higher throughput, online sensing, and commercialization pathways.

Key Information: Clinical trials are not allowed; only U.S. small businesses are eligible; milestone-driven cooperative agreement with NIH programmatic involvement.